Literature DB >> 18357424

Update on subarachnoid haemorrhage.

José M Ferro1, P Canhão, R Peralta.   

Abstract

Subarachnoid haemorrhage (SAH) is less frequent than ischaemic stroke or intracerebral haemorrhage, but has a high public health relevance because it can affect young and middle-age adults, has considerable mortality and morbidity, it is treatable and preventable. SAH is traditionally a topic for neurosurgeons. However as endovascular interventions are becoming effective alternatives to surgical treatment, SAH should turn out to be of interest to neurologists, in particular to those devoted to stroke, emergency and neurointensive care. Despite stable incidence, the mortality of SAH has decreased in the last two decades due to better neurosurgical techniques and neurocritical care and to advances in interventional neuroradiological procedures. We review the recent advances in the clinical and diagnostic aspects of SAH and in the genetics of intracranial aneurysms. A systematic review of the treatment of SAH and grading of the available evidence is included.

Entities:  

Mesh:

Year:  2008        PMID: 18357424     DOI: 10.1007/s00415-008-0606-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  109 in total

1.  Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol.

Authors:  M K Morgan; B Jonker; S Finfer; T Harrington; N W Dorsch
Journal:  J Clin Neurosci       Date:  2000-07       Impact factor: 1.961

2.  Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology.

Authors:  S Claiborne Johnston; Randall T Higashida; Daniel L Barrow; Louis R Caplan; Jacques E Dion; George Hademenos; L Nelson Hopkins; Andrew Molyneux; Robert H Rosenwasser; Fernando Vinuela; Charles B Wilson
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

3.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

4.  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Authors:  Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

5.  Prognostic value of intraventricular blood in perimesencephalic nonaneurysmal subarachnoid hemorrhage.

Authors:  G Franz; C Brenneis; A Kampfl; B Pfausler; W Poewe; E Schmutzhard
Journal:  J Comput Assist Tomogr       Date:  2001 Sep-Oct       Impact factor: 1.826

6.  Risk factors for continued cigarette use after subarachnoid hemorrhage.

Authors:  Jennifer Ballard; Kurt T Kreiter; Jan Claassen; Robert G Kowalski; E Sander Connolly; Stephan A Mayer
Journal:  Stroke       Date:  2003-07-03       Impact factor: 7.914

Review 7.  "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.

Authors:  Kendall H Lee; Timothy Lukovits; Jonathan A Friedman
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

8.  Sudden onset headache: a prospective study of features, incidence and causes.

Authors:  A-M Landtblom; S Fridriksson; J Boivie; J Hillman; G Johansson; I Johansson
Journal:  Cephalalgia       Date:  2002-06       Impact factor: 6.292

Review 9.  Cerebral vasospasm after subarachnoid hemorrhage.

Authors:  Nazli Janjua; Stephan A Mayer
Journal:  Curr Opin Crit Care       Date:  2003-04       Impact factor: 3.687

10.  Risk factors for subarachnoid hemorrhage: a systematic review.

Authors:  L L Teunissen; G J Rinkel; A Algra; J van Gijn
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more
  20 in total

1.  Correlating Cerebral (18)FDG PET-CT Patterns with Histological Analysis During Early Brain Injury in a Rat Subarachnoid Hemorrhage Model.

Authors:  Jianping Song; Peiliang Li; Neeraj Chaudhary; Joseph J Gemmete; B Gregory Thompson; Guohua Xi; Aditya S Pandey
Journal:  Transl Stroke Res       Date:  2015-04-03       Impact factor: 6.829

2.  No evidence for an association between genetic variation at the MMP2 and MMP9 loci and aneurysmal subarachnoid haemorrhage.

Authors:  Sandra Olsson; Ludvig Z Csajbok; Katarina Jood; Karin Nylén; Bengt Nellgård; Christina Jern
Journal:  J Neurol       Date:  2011-07-07       Impact factor: 4.849

3.  Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.

Authors:  Xi Zoë Zhong; Maksym I Harhun; Soren P Olesen; Susumu Ohya; James D Moffatt; William C Cole; Iain A Greenwood
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

Review 4.  Intracranial hemorrhage.

Authors:  J Alfredo Caceres; Joshua N Goldstein
Journal:  Emerg Med Clin North Am       Date:  2012-08       Impact factor: 2.264

5.  Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.

Authors:  Alan K H Tam; Don Ilodigwe; Jay Mocco; Stephan Mayer; Neal Kassell; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

Review 6.  Thrombectomy for ischemic stroke: meta-analyses of recurrent strokes, vasospasms, and subarachnoid hemorrhages.

Authors:  Robert Emprechtinger; Brigitte Piso; Peter A Ringleb
Journal:  J Neurol       Date:  2016-06-20       Impact factor: 4.849

Review 7.  Early endovascular treatment of subarachnoid hemorrhage.

Authors:  Jordi A Matias-Guiu; Carmen Serna-Candel
Journal:  Interv Neurol       Date:  2013-03

8.  Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Mark K Donnelly; Yvette P Conley; Elizabeth A Crago; Dianxu Ren; Paula R Sherwood; Jeffery R Balzer; Samuel M Poloyac
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-12       Impact factor: 6.200

9.  Knowledge of stroke risk factors among primary care patients with previous stroke or TIA: a questionnaire study.

Authors:  Andrzej Sloma; Lars G Backlund; Lars-Erik Strender; Ylva Skånér
Journal:  BMC Fam Pract       Date:  2010-06-15       Impact factor: 2.497

Review 10.  [Aneurysmal subarachnoid hemorrhage].

Authors:  P Kellner; D Stoevesandt; J Soukup; M Bucher; C Raspé
Journal:  Anaesthesist       Date:  2012-09       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.